Development and validation of an LC-MS/MS method for the quantification of free and total doxorubicin in human plasma and its clinical application for a novel doxorubicin hydrochloride liposome injection in Chinese patients with breast cancer
Crossref DOI link: https://doi.org/10.1556/1326.2023.01129
Published Print: 2024-09-02
Update policy: https://doi.org/10.1556/policypage.crossmark.crossref.2
Zhang, Keyu
Zhang, Daqing
Ge, Zhicheng
Qiu, Feng https://orcid.org/0000-0002-9945-0612
Funding for this research was provided by:
National Natural Science Foundation of China (82174062)
National Natural Science Foundation of China (81573682)
License valid from 2024-09-02
